BiolineRX Wins U.S. Patent for Heart Attack Drug
BiolineRX announced that it has obtained a U.S. patent for the composition of BL-1040, its novel medical device for prevention of cardiac remodeling following an acute myocardial infarction.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.